Position history for US BANCORP \DE\'s holdings in INOVIO PHARMACEUTICALS INC
US BANCORP \DE\ previously held 0 shares of INO (INOVIO PHARMACEUTICALS INC), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$1,172
Total Shares Change
-145
Other major holders of INO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $2.44 |
0 |
| 2025-Q2 | Decreased | 62 | -12.7% | $126 | 0.0% | $2.11 | 0 |
| 2025-Q1 | Increased | 71 | +14.5% | $116 | 0.0% | $1.73 | 9 |
| 2024-Q4 | Decreased | 62 | -57.2% | $113 | 0.0% | $1.78 | 0 |
| 2024-Q3 | Unchanged | 145 | 0.0% | $838 | 0.0% | $5.86 | 0 |
| 2024-Q2 | Unchanged | 145 | 0.0% | $1,172 | 0.0% | $8.08 | 0 |